Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAPLE: Prednisolone in Severe Eosinophilic Asthma on Mepolizumab
NCT03610685Phase 4Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Oct 2018
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisolone in eosinophilic asthma (EA), sponsored by NHS Greater Glasgow and Clyde. Started Oct 2018; status: completed.
02
Drugs
prednisolone
03
Conditions
eosinophilic asthma (EA)
Beyond the preview
Go deeper on NCT03610685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03610685.